AP NEWS

Global Influenza Market: Size, Trends and Forecast (2018-2022) with GlaxoSmithKline, AstraZeneca, Thermo Fisher Scientific, and Abbott Laboratories Dominating - ResearchAndMarkets.com

December 3, 2018

DUBLIN--(BUSINESS WIRE)--Dec 3, 2018--The “Global Influenza Market: Size, Trends and Forecast (2018-2022)” report has been added to ResearchAndMarkets.com’s offering.

The global influenza market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2018-2022).

The market is expected to be driven by various growth enhancing factors such as aging population, increasing awareness about influenza prevention, growing government initiatives to counter influenza, increasing healthcare expenditure and growing prevalence of chronic diseases.

However, the market is not free from challenges that are hindering its growth. Some of the major challenges faced by the market are the high cost of vaccine development and the low influenza vaccination awareness in developing countries.

The global influenza market has been segmented into vaccines, diagnostics and therapeutics. The influenza diagnostic market has been further segmented on the basis of test types into reverse transcription polymerase chain reaction (RT-PCR), rapid influenza diagnostic test (RIDT) and cell culture.

The major players dominating the influenza market are GlaxoSmithKline (GSK), AstraZeneca, Thermo Fisher Scientific and Abbott Laboratories. The four companies have been profiled in the report providing detailed analysis of their financial information and business strategies.

Market Dynamics

Growth Drivers

Aging Population Increasing Healthcare Expenditure Growing Prevalence of Chronic Diseases Increasing Awareness about Influenza Prevention Growing Government Initiatives to Counter Influenza

Challenges

High Cost of Vaccine Development Low Influenza Vaccination Awareness in Developing Countries

Trends

Increasing Vaccination Coverage Use of Intranasal Influenza Vaccines Cell Culture Technology Development of Point-of-Care Molecular Tests

Companies Profiled

GlaxoSmithKline (GSK) AstraZeneca Thermo Fisher Scientific Abbott Laboratories

Key Topics Covered

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. Regional Market Analysis

5. Market Dynamics

6. Competitive Landscape

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/nz7pwn/global_influenza?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181203005430/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/03/2018 06:33 AM/DISC: 12/03/2018 06:33 AM

http://www.businesswire.com/news/home/20181203005430/en

AP RADIO
Update hourly